Andres Maldonado HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
59
Avg Return
Past Year
Past Year
29%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
93.8%
Neutral
6.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Reiterated
| $9 |
241%
upside
| 2 | +16% |
0
%
| 16 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $20 |
5%
downside
| 3 | +87% |
0
%
| 13 Mar ‘26 1 month ago |
|
|
|
Buy
Reiterated
| $13 |
139%
upside
| 1 | +12% |
0
%
| 10 Mar ‘26 1 month ago |
|
|
|
Neutral
Downgraded
| $21.50 |
0%
upside
| 2 | +42% |
0
%
| 10 Mar ‘26 1 month ago |
|
|
|
Buy
Reiterated
| $25 |
200%
upside
| 1 | +14% |
0
%
| 9 Mar ‘26 1 month ago |
|
|
|
Buy
Reiterated
| $58 |
20%
upside
| 2 | +9.3% |
0
%
| 3 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $80 |
11%
upside
| 1 | +15% |
0
%
| 27 Feb ‘26 1 month ago |
|
|
|
Buy
Maintained
| $15 |
81%
upside
| 2 | +30% |
0
%
| 23 Feb ‘26 1 month ago |
|
|
|
Buy
Initiated
| $40 |
63%
upside
| 1 | -12% |
0
%
| 12 Feb ‘26 2 months ago |
|
|
|
Buy
Reiterated
| $23 |
335%
upside
| 1 | +9.2% |
0
%
| 10 Feb ‘26 2 months ago |
|
|
|
Buy
Assumed
| $18 |
180%
upside
| 1 | -8.7% |
0
%
| 4 Feb ‘26 2 months ago |
|